Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NADH-dependent oxidoreductases are a broad class of enzymes that catalyze the transfer of electrons from NADH to various electron acceptors, such as flavins (FMN, FAD), quinones, or ferredoxins, playing a central role in cellular redox metabolism and energy production[1][2][3][4][5]. These enzymes often contain flavin cofactors and share conserved structural motifs but can differ in substrate specificity and physiological roles depending on the organism and context[3][4]. Important representatives include NADH:FMN oxidoreductase, NADH:quinone oxidoreductase (NDH-2), and ferredoxin:NADP+ oxidoreductase (Nfn), among others[2][4]. Their physiological functions extend across oxidative phosphorylation in mitochondria, metabolic fermentation in bacteria, and redox homeostasis in various cell types. They are considered potential therapeutic targets in cancer and infection due to their involvement in mitochondrial and bacterial electron transport, but selectivity and safety remain significant challenges[4].
Competitive or noncompetitive inhibition of electron transfer from NADH to acceptors (such as FMN, quinone, or ferredoxin)[1][2][4][5] Modulation of mitochondrial or bacterial electron transport chain
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NADH-dependent oxidoreductase.